Latest Middle East News

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

Lotus Resources has halted production at its Kayelekera uranium mine due to acid supply interruptions linked to Middle East geopolitics and acid plant issues, while advancing export permits and pursuing new funding arrangements.

Worley has revised its FY26 underlying EBITA impact from the Middle East conflict to up to $60 million, doubling its previous estimate, while also warning of a $50 million hit from foreign currency translation due to a stronger Australian dollar.

Bankers Investment Trust reported a 3.7% NAV total return for the half-year to April 2026, outpacing the FTSE World Index, while declaring a 3.1% dividend increase. Fund manager Alex Crooke announced retirement, with Richard Clode set to take the helm.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Buru Energy has launched a prospectus offering over 207 million new options free-attaching to a recent $5.3 million placement, aiming to back the commercialisation of its Rafael Gas Project and bolster working capital.

Australian Agricultural Company (ASX:AAC) defied North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Harvest Technology Group has transitioned from assessing to actively executing its international defence market strategy by engaging a US national security advisory firm and appointing Dr Oleksandra Molloy as Defence Strategic Advisor for Europe.

Flight Centre Travel Group has trimmed its FY26 profit forecast due to Middle East conflict impacts on leisure travel, while launching a fresh $200 million share buy-back reflecting confidence in recovery.